In this episode of the APAPP podcast, Corinne Young and Amanda Michaud discuss the current landscape of biologic therapies for asthma, focusing on the six available biologics, their mechanisms, and how to choose the right one for patients. They delve into the importance of biomarkers, particularly eosinophil counts, in guiding treatment decisions. The conversation also covers the differences in treatment approaches for pediatric and adult patients, the role of comorbidities, and the future of biologic therapies. Additionally, they explore the relationship between immunotherapy and biologic therapy, emphasizing the need for careful patient management and collaboration between specialists.

Send us a text

Claim your 0.5 CME credits for listening to this episode here: https://forms.gle/42yHmF8UpemVhdDJA

Visit our website for more APP Pulmonary, Critical Care, and Sleep Medicine content and free CMEs www.pulmapp.com

Follow us on:

• Instagram @pulmapps
• Twitter@pulmapp
• Facebook @association of pulmonary advance practice providers.